Goldenwell Biotech, INC 8-K filings
Current reports — the filing a company makes when something happens that shareholders need to know about before the next quarterly report.
OTC.Pink
Goldenwell Biotech, Inc. announced the appointment of Ming Zhou to its board of directors, accompanied by a substantial share gift from the CEO.
OTC.Pink
Goldenwell Biotech, Inc. has dismissed its independent auditor, Michael Gillespie & Associates, PLLC, citing the auditor's report included substantial doubt about the company's ability to continue as a going concern.
OTC.Pink
Goldenwell Biotech, Inc. announced a change in its independent registered public accounting firm, with KCCW Accountancy Corp. resigning and Michael Gillespie & Associates, PLLC appointed, following KCCW's going concern warning.
OTC.Pink
Goldenwell Biotech dismisses Michael Gillespie & Associates as their independent auditor and appoints KCCW Accountancy Corp. effective January 23, 2025.
OTC.Pink
Goldenwell Biotech has dismissed Yusufali & Associates as its auditor after the PCAOB revoked their registration, and has engaged Michael Gillespie & Associates as its new auditor.
OTC.Pink
Goldenwell Biotech has dismissed BF Borgers CPA PC as its independent auditor and appointed Yusufali & Associates, LLC, effective May 15, 2024.